BackgroundMarburg virus (MARV). an Ebola-like virus. remains an eminent threat to public health as demonstrated by its high associated mortality rate (23-90%) and recent emergence in West Africa for the first time. Although a recombinant vesicular stomatitis virus (rVSV)-based vaccine (Ervebo) is licensed for Ebola virus disease (EVD). https://www.chiggate.com/majirel-majicontrast-red-rouge-for-sale/